Gamma interferon 1b: CNCT began Phase III testing

Connective Therapeutics Inc. (CNCT), Palo Alto, Calif. Product: Gamma interferon 1b Indication: Severe atopic dermatitis Status: CNCT began Phase III testing in 500 patients, who will receive 50 µg/m ...